BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34959779)

  • 1. Effect of Vitamin E Supplement on Bone Turnover Markers in Postmenopausal Osteopenic Women: A Double-Blind, Randomized, Placebo-Controlled Trial.
    Vallibhakara SA; Nakpalat K; Sophonsritsuk A; Tantitham C; Vallibhakara O
    Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a Multispecies Probiotic Supplement on Bone Health in Osteopenic Postmenopausal Women: A Randomized, Double-blind, Controlled Trial.
    Jafarnejad S; Djafarian K; Fazeli MR; Yekaninejad MS; Rostamian A; Keshavarz SA
    J Am Coll Nutr; 2017; 36(7):497-506. PubMed ID: 28628374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of isolated vitamin D supplementation on bone turnover markers in younger postmenopausal women: a randomized, double-blind, placebo-controlled trial.
    Nahas-Neto J; Cangussu LM; Orsatti CL; Bueloni-Dias FN; Poloni PF; Schmitt EB; Nahas EAP
    Osteoporos Int; 2018 May; 29(5):1125-1133. PubMed ID: 29450585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Multispecies Probiotic Supplementation on Serum Bone Turnover Markers in Postmenopausal Women with Osteopenia: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Vanitchanont M; Vallibhakara SA; Sophonsritsuk A; Vallibhakara O
    Nutrients; 2024 Feb; 16(3):. PubMed ID: 38337745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tocotrienol supplementation suppressed bone resorption and oxidative stress in postmenopausal osteopenic women: a 12-week randomized double-blinded placebo-controlled trial.
    Shen CL; Yang S; Tomison MD; Romero AW; Felton CK; Mo H
    Osteoporos Int; 2018 Apr; 29(4):881-891. PubMed ID: 29330573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of green tea and Tai Chi on bone health in postmenopausal osteopenic women: a 6-month randomized placebo-controlled trial.
    Shen CL; Chyu MC; Yeh JK; Zhang Y; Pence BC; Felton CK; Brismée JM; Arjmandi BH; Doctolero S; Wang JS
    Osteoporos Int; 2012 May; 23(5):1541-52. PubMed ID: 21766228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potassium Citrate Supplementation Decreases the Biochemical Markers of Bone Loss in a Group of Osteopenic Women: The Results of a Randomized, Double-Blind, Placebo-Controlled Pilot Study.
    Granchi D; Caudarella R; Ripamonti C; Spinnato P; Bazzocchi A; Massa A; Baldini N
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30213095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial.
    Cheung AM; Tile L; Lee Y; Tomlinson G; Hawker G; Scher J; Hu H; Vieth R; Thompson L; Jamal S; Josse R
    PLoS Med; 2008 Oct; 5(10):e196. PubMed ID: 18922041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of calcium and vitamin D supplementation with and without collagen peptides on bone turnover in postmenopausal women with osteopenia.
    Argyrou C; Karlafti E; Lampropoulou-Adamidou K; Tournis S; Makris K; Trovas G; Dontas I; Triantafyllopoulos IK
    J Musculoskelet Neuronal Interact; 2020 Mar; 20(1):12-17. PubMed ID: 32131366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligopin® Supplementation Mitigates Oxidative Stress in Postmenopausal Women with Osteopenia: A Randomized, Double-blind, Placebo-Controlled Trial.
    Majidi Z; Ansari M; Maghbooli Z; Ghasemi A; Ebrahimi SSS; Hossein-Nezhad A; Emamgholipour S
    Phytomedicine; 2021 Jan; 81():153417. PubMed ID: 33250314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of French maritime pine bark extract (Oligopin®) supplementation on bone remodeling markers in postmenopausal osteopenic women: A randomized clinical trial.
    Panahande SB; Maghbooli Z; Hossein-Nezhad A; Qorbani M; Moeini-Nodeh S; Haghi-Aminjan H; Hosseini S
    Phytother Res; 2019 Apr; 33(4):1233-1240. PubMed ID: 30907034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of vitamin E on bone turnover markers among US postmenopausal women.
    Hamidi MS; Corey PN; Cheung AM
    J Bone Miner Res; 2012 Jun; 27(6):1368-80. PubMed ID: 22308007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined bioavailable isoflavones and probiotics improve bone status and estrogen metabolism in postmenopausal osteopenic women: a randomized controlled trial.
    Lambert MNT; Thybo CB; Lykkeboe S; Rasmussen LM; Frette X; Christensen LP; Jeppesen PB
    Am J Clin Nutr; 2017 Sep; 106(3):909-920. PubMed ID: 28768651
    [No Abstract]   [Full Text] [Related]  

  • 14. Supplementation with calcium and short-chain fructo-oligosaccharides affects markers of bone turnover but not bone mineral density in postmenopausal women.
    Slevin MM; Allsopp PJ; Magee PJ; Bonham MP; Naughton VR; Strain JJ; Duffy ME; Wallace JM; Mc Sorley EM
    J Nutr; 2014 Mar; 144(3):297-304. PubMed ID: 24453130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium and vitamin d supplementation in postmenopausal women.
    Aloia JF; Dhaliwal R; Shieh A; Mikhail M; Islam S; Yeh JK
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1702-9. PubMed ID: 24064695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplementation with the antioxidant lycopene significantly decreases oxidative stress parameters and the bone resorption marker N-telopeptide of type I collagen in postmenopausal women.
    Mackinnon ES; Rao AV; Josse RG; Rao LG
    Osteoporos Int; 2011 Apr; 22(4):1091-101. PubMed ID: 20552330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A calcium-collagen chelate dietary supplement attenuates bone loss in postmenopausal women with osteopenia: a randomized controlled trial.
    Elam ML; Johnson SA; Hooshmand S; Feresin RG; Payton ME; Gu J; Arjmandi BH
    J Med Food; 2015 Mar; 18(3):324-31. PubMed ID: 25314004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vitamin D analogue 2MD increases bone turnover but not BMD in postmenopausal women with osteopenia: results of a 1-year phase 2 double-blind, placebo-controlled, randomized clinical trial.
    DeLuca HF; Bedale W; Binkley N; Gallagher JC; Bolognese M; Peacock M; Aloia J; Clagett-Dame M; Plum L
    J Bone Miner Res; 2011 Mar; 26(3):538-45. PubMed ID: 20890933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal Change in Biomarkers of Bone Turnover Following Late Evening Ingestion of a Calcium-Fortified, Milk-Based Protein Matrix in Postmenopausal Women with Osteopenia.
    Hettiarachchi M; Cooke R; Norton C; Jakeman P
    Nutrients; 2019 Jun; 11(6):. PubMed ID: 31234587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of 1-year transdermal estrogen replacement therapy on bone mineral density and biochemical markers of bone turnover in osteopenic postmenopausal systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.
    Bhattoa HP; Bettembuk P; Balogh A; Szegedi G; Kiss E
    Osteoporos Int; 2004 May; 15(5):396-404. PubMed ID: 14676992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.